These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 235218)

  • 41. The pathophysiology of renovascular hypertension.
    Robertson JI; Morton JJ; Tillman DM; Lever AF
    J Hypertens Suppl; 1986 Oct; 4(4):S95-103. PubMed ID: 3534187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for a significant contribution from central effects of angiotensin in the development of acute renal hypertension in the greyhound.
    Scoop GC; Katic FP; Brown MJ; Cain MD; Zeegers PJ
    Clin Sci Mol Med; 1975 Feb; 48(2):115-9. PubMed ID: 1116331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of angiotensin-converting enzyme for diagnosis of renal-artery stenosis.
    Re R; Novelline R; Escourrou MT; Athanasoulis C; Burton J; Haber E
    N Engl J Med; 1978 Mar; 298(11):582-6. PubMed ID: 203850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of removing the clipped kidney on renovascular hypertension in rabbits.
    Fujii J; Yazaki Y; Seki A; Kuramochi M; Muraki H
    Jpn Heart J; 1974 Nov; 15(6):615-22. PubMed ID: 4463268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renin-angiotensin system in an infant with malignant renovascular hypertension.
    Fyhrquist F; Kuitunen P; Kojo N
    Helv Paediatr Acta; 1976 Jun; 31(1):61-5. PubMed ID: 939701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypertension and the interrelated renal circulatory effects of prostaglandins and the renin-angiotensin system.
    Romero JC; Strong CG
    Mayo Clin Proc; 1977 Jul; 52(7):462-4. PubMed ID: 875471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of 1-sarcosine-8-isoleucine-angiotensin II on blood pressure and plasma renin activity in various types of hypertension.
    Yasujima M; Abe K; Aoyagi H; Irokawa N; Memezawa H
    Tohoku J Exp Med; 1975 Jul; 116(3):277-83. PubMed ID: 1179425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension.
    Naitoh M; Suzuki H; Arakawa K; Matsumoto A; Ichihara A; Matsuda H; Kubota E; Murakami M; Nakamoto H; Saruta T
    Am J Physiol; 1997 Feb; 272(2 Pt 2):H679-87. PubMed ID: 9124424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renin. Its release mechanisms and its vasoconstrictive effects in renovascular hypertension.
    Eide I
    J Oslo City Hosp; 1975 Mar; 25(3):37-54. PubMed ID: 1127493
    [No Abstract]   [Full Text] [Related]  

  • 50. Circulatory and humoral changes in the reversal of renovascular hypertension in sheep by unclipping the renal artery.
    Funder JW; Blair-West JR; Cain MC; Catt KJ; Coghlan JP; Denton DA; Nelson JF; Scoggins BA; Wright RD
    Circ Res; 1970 Aug; 27(2):249-58. PubMed ID: 4318417
    [No Abstract]   [Full Text] [Related]  

  • 51. [Studies on hypertension: I) The effects of angiotensin II and norepinephrine infusion on renal hemodynamics and renin angiotensin system in anesthetized dogs. II) The metabolism of 3H-DOPA in two kidney Goldblatt dogs (author's transl)].
    Kita T
    Nihon Jinzo Gakkai Shi; 1978 Aug; 20(8):931-41. PubMed ID: 713169
    [No Abstract]   [Full Text] [Related]  

  • 52. Renovascular hypertension. Relationship of surgical curability to renin-angiotensin activity.
    Tucker RM; Strong CG; Brennan LA; Sheps SG; Brown RD; Weinshilboum RM
    Mayo Clin Proc; 1978 Jun; 53(6):373-7. PubMed ID: 651381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of high sodium intake and angiotensin antagonist in rabbits with severe and moderate hypertension induced by constriction of one renal artery.
    Romero JC; Holmes DR; Strong CG
    Circ Res; 1977 May; 40(5 Suppl 1):I17-23. PubMed ID: 870227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of the renin--angiotensin system in experimental renal hypertension in dogs.
    Johnson JA; Davis JO; Spielman WS; Freeman RH
    Proc Soc Exp Biol Med; 1974 Nov; 147(2):387-91. PubMed ID: 4373756
    [No Abstract]   [Full Text] [Related]  

  • 55. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The inhibition of angiotensin converting enzyme in chronic renal hypertension by a synthetic peptide.
    Loyke HF
    Proc Soc Exp Biol Med; 1975 Nov; 150(2):457-60. PubMed ID: 174133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of converting enzyme blockade on isoprenaline- and angiotensin I-induced drinking.
    Hertting G; Meyer DK
    Br J Pharmacol; 1974 Nov; 52(3):381-6. PubMed ID: 4376436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequential renal hemodynamics in experimental benign and malignant hypertension.
    Dzau VJ; Siwek LG; Rosen S; Farhi ER; Mizoguchi H; Barger AC
    Hypertension; 1981; 3(3 Pt 2):I63-8. PubMed ID: 7021415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of experimental renovascular hypertension by caval portal shunt.
    Reichle FA; Hower RD; Bernstein MR; Reichle RM; Rosemond GP
    Arch Surg; 1972 Oct; 105(4):599-603. PubMed ID: 4341908
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanism of renal hypertension.
    Brown JJ; Davies DL; Morton JJ; Robertson JI; Cuesta V; Lever AF; Padfield PL; Trust P
    Lancet; 1976 Jun; 1(7971):1219-21. PubMed ID: 58263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.